While prior reports have suggested CRP elevation in advanced liver disease stages such as cirrhosis or HCC, our findings indicate that CRP is not a useful biomarker of viral activity in the early phase [34,35]. This evidence concerns the gene CRP and hepatocellular carcinoma.